These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 20363294
1. The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response. Zarrindast MR, Naghdi-Sedeh N, Nasehi M, Sahraei H, Bahrami F, Asadi F. Neurosci Lett; 2010 May 21; 475(3):156-60. PubMed ID: 20363294 [Abstract] [Full Text] [Related]
2. Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems. Zarrindast MR, Mahboobi S, Sadat-Shirazi MS, Ahmadi S. J Psychopharmacol; 2011 Jan 21; 25(1):131-40. PubMed ID: 20685770 [Abstract] [Full Text] [Related]
3. Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors. Rezayof A, Hosseini SS, Zarrindast MR. Behav Brain Res; 2009 Sep 14; 202(2):171-8. PubMed ID: 19463698 [Abstract] [Full Text] [Related]
4. D1 and D2 dopaminergic systems in the rat basolateral amygdala are involved in anxiogenic-like effects induced by histamine. Bananej M, Karimi-Sori A, Zarrindast MR, Ahmadi S. J Psychopharmacol; 2012 Apr 14; 26(4):564-74. PubMed ID: 21628344 [Abstract] [Full Text] [Related]
5. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system. Zarrindast MR, Sroushi A, Bananej M, Vousooghi N, Hamidkhaniha S. Eur J Pharmacol; 2011 Dec 15; 672(1-3):106-12. PubMed ID: 21968140 [Abstract] [Full Text] [Related]
6. Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors. Zarrindast MR, Khalifeh S, Rezayof A, Rostami P, Aghamohammadi Sereshki A, Zahmatkesh M. Brain Res; 2012 Jun 15; 1460():25-32. PubMed ID: 22595749 [Abstract] [Full Text] [Related]
7. Dopaminergic system in CA1 modulates MK-801 induced anxiolytic-like responses. Zarrindast MR, Nasehi M, Pournaghshband M, Yekta BG. Pharmacol Biochem Behav; 2012 Nov 15; 103(1):102-10. PubMed ID: 22885281 [Abstract] [Full Text] [Related]
8. Modulation of ventral tegmental area dopamine receptors inhibit nicotine-induced anxiogenic-like behavior in the central amygdala. Zarrindast MR, Eslahi N, Rezayof A, Rostami P, Zahmatkesh M. Prog Neuropsychopharmacol Biol Psychiatry; 2013 Mar 05; 41():11-7. PubMed ID: 23178824 [Abstract] [Full Text] [Related]
9. The effects of nicotine on nitric oxide induced anxiogenic-like behaviors in the dorsal hippocampus. Piri M, Nasehi M, Shahab Z, Zarrindast MR. Neurosci Lett; 2012 Oct 24; 528(2):93-8. PubMed ID: 22985517 [Abstract] [Full Text] [Related]
10. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats. Zarrindast MR, Solati J, Oryan S, Parivar K. Pharmacology; 2008 Oct 24; 82(4):276-84. PubMed ID: 18849647 [Abstract] [Full Text] [Related]
11. Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats. Reza Zarrindast M, Eslimi Esfahani D, Oryan S, Nasehi M, Torabi Nami M. Eur J Pharmacol; 2013 Feb 28; 702(1-3):25-31. PubMed ID: 23376414 [Abstract] [Full Text] [Related]
12. Involvement of the dorsal hippocampal dopamine D2 receptors in histamine-induced anxiogenic-like effects in mice. Piri M, Ayazi E, Zarrindast MR. Neurosci Lett; 2013 Aug 29; 550():139-44. PubMed ID: 23872092 [Abstract] [Full Text] [Related]
14. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours. Rostami P, Hajizadeh-Moghaddam A, Zarrindast MR. Physiol Behav; 2006 May 30; 87(5):891-6. PubMed ID: 16600315 [Abstract] [Full Text] [Related]
15. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test. Rezvanfard M, Zarrindast MR, Bina P. Pharmacology; 2009 May 30; 84(6):356-66. PubMed ID: 19907194 [Abstract] [Full Text] [Related]
16. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Zarrindast MR, Babapoor-Farrokhran S, Babapoor-Farrokhran S, Rezayof A. Life Sci; 2008 Jun 06; 82(23-24):1175-81. PubMed ID: 18456284 [Abstract] [Full Text] [Related]
18. Withdrawal from repeated administration of morphine alters histamine-induced anxiogenic effects produced by intra-ventral hippocampal microinjection. Zarrindast MR, Khodarahmi P, Rezayof A, Oryan S. J Psychopharmacol; 2010 Jun 06; 24(6):881-9. PubMed ID: 20093321 [Abstract] [Full Text] [Related]
19. The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Zarrindast MR, Torabi M, Rostami P, Fazli-Tabaei S. Pharmacol Biochem Behav; 2006 Nov 06; 85(3):500-6. PubMed ID: 17109942 [Abstract] [Full Text] [Related]
20. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Zarrindast MR, Sarahroodi S, Arzi A, Khodayar MJ, Taheri-Shalmani S, Rezayof A. Behav Pharmacol; 2008 Oct 06; 19(7):716-23. PubMed ID: 18797248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]